Clinical Trials Logo

Clostridium Difficile Infection clinical trials

View clinical trials related to Clostridium Difficile Infection.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT03848689 Enrolling by invitation - Clinical trials for Clostridium Difficile Infection

FQ Restriction for the Prevention of CDI

FIRST
Start date: May 1, 2019
Phase:
Study type: Observational

This study evaluates the effectiveness of a new intervention, fluoroquinolone (FQ) Preprescription Authorization (PPA) strategy, to reduce and prevent Clostridium difficile infection (CDI) in hospital intensive care units (ICUs). The investigators will model a successful FQ PPA strategy in several Wisconsin ICUs and compare whether the intervention has improved outcomes in reducing CDIs. An additional goal of the study is to evaluate environmental and work system factors using systems engineering models in order to determine the most successful way to implement these new strategies.